infomed-screen
Hochdosistherapie bei Non-Hodgkin-Lymphom nicht lohnend
- r -- Kluin-Nelemans HC, Zagonel V, Anastasopoulou A et al. Standard chemotherapy with or without high-dose chemotherapy for aggressive non-hodgkin’s lymphoma: randomized phase III EORTC study. J Natl Cancer Inst 2001 (3. Januar); 93: 22-30 [Link]